**Ovarian Cancer Metastasis: A Unique Mechanism of Dissemination**

Anirban K. Mitra

tunnel formation in 3D collagen matrices. J. Cell Sci. 2009;122:4558–4569. doi:10.1242/

[81] Carey SP, Starchenko A, McGregor AL, Reinhart‐King CA. Leading malignant cells initiate collective epithelial cell invasion in a three‐dimensional heterotypic tumor spheroid model. Clin. Exp. Metastasis. 2013;30:615–630. doi:10.1007/s10585‐013‐9565‐

[82] Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110:673–

[83] Zacharia LC, Gkretsi V. Cancer cell metastasis; perspectives from the focal adhesions.

[84] Peinado H, Lavotshkin S, Lyden D. The secreted factors responsible for premetastatic niche formation: old sayings and new thoughts. Semin. Cancer Biol. 2011;21:139–146.

[85] Psaila B, and Lyden D. The metastatic niche: adapting the foreign soil. Nat. Rev. Cancer.

[86] Shibue T, Weinberg RA. Metastatic colonization: settlement, adaptation and propaga‐ tion of tumor cells in a foreign tissue environment. Semin. Cancer Biol. 2011;21:99–106.

[87] Oskarsson T, Acharyya S, Zhang XH, Vanharanta S, Tavazoie SF, Morris PG, et al. Breast cancer cells produce tenascin c as a metastatic niche component to colonize the

[88] Shibue T, Weinberg RA. Integrin beta1‐focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs. Proc. Natl. Acad. Sci.

[89] Chiang AC, Massague J. Molecular basis of metastasis. The N. Eng. J. Med.

[90] Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving

[91] Lorusso G, Rüegg C. New insights into the mechanisms of organ‐specific breast cancer metastasis. Semin. Cancer Biol. 2012;22:226–233. doi:10.1016/j.semcancer.2012.03.007.

Adv. Mod. Oncol. Res. 2015;1:2–7. doi:10.18282/amor.v1.i1.6.

lungs. Nat. Med. 2011;17:867–874. doi:10.1038/nm.2379.

USA. 2009;106:10290–10295. doi:10.1073/pnas.0904227106.

paradigms. Cell. 2011;147:275–292. doi:10.1016/j.cell.2011.09.024.

2008;359:2814–2823. doi:10.1056/NEJMra0805239.

jcs.050724.

687. doi:10.1016/S0092‐8674(02)00971‐6.

doi:10.1016/j.semcancer.2011.01.002.

2009;9:285–293. doi:10.1038/nrc2621.

doi:10.1016/j.semcancer.2010.12.003.

x.

42 Tumor Metastasis

Additional information is available at the end of the chapter

http://dx.doi.org/DOI:10.5772/64700

#### **Abstract**

Ovarian cancer is the most lethal of all gynecologic malignancies and has witnessed minimal improvements in patient outcomes in the past three decades. About 70% of ovarian cancer patients present with disseminated disease at the time of diagnosis. The standard of care remains a combination of debulking surgery and platinum‐ and taxanes‐based cytotoxic chemotherapy. Even though metastasis is the leading cause of ovarian cancer related fatalities, our understanding of the process remains limited. Ovarian cancer has a unique pattern of metastasis where the hematogenous spread is less common. Ovarian cancer cells mainly metastasize within the peritoneal cavity, which involves exfoliation from the primary tumor, survival, and transport in the peritoneal fluid followed by metastatic colonization of the organs within the perito‐ neal cavity. A key step for successful metastasis is their attachment and productive interactions with the mesothelial cells covering the metastatic organs for the establish‐ ment of metastatic tumors. This chapter provides an overview of ovarian cancer metastasis highlighting the unique dissemination and the underlying mechanisms of regulation of the steps involved. The role of the microenvironment in the process of metastasis will also be reviewed.

**Keywords:** ovarian cancer, metastasis, omentum, microenvironment, ascites
